SYSTEMIC MASTOCYTOSIS - A CASE TREATED WITH INTERFERON-ALPHA AND RADIOTHERAPY

被引：0
|
作者：
HARRISON, BD
ASHFORD, RA
HATTON, CSR
机构：
[1] HEATHERWOOD HOSP TRUST,SLOUGH SL2 4HL,BERKS,ENGLAND
[2] WEXHAM PK HOSP TRUST,SLOUGH SL2 4HL,BERKS,ENGLAND
[3] MT VERNON HOSP,MT VERNON CTR CANC TREATMENT,NORTHWOOD HA6 2RN,MIDDX,ENGLAND
来源：
CLINICAL AND LABORATORY HAEMATOLOGY | 1994年 / 16卷 / 03期
关键词：
SYSTEMIC MASTOCYTOSIS; INTERFERON ALPHA; RADIOTHERAPY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Systemic mastocytosis is uncommon. Symptoms result from local infiltration and degranulation of mast cells. Reports in the literature describe successful use of interferon alpha and radiotherapy to produce reduction in symptoms and bulk of disease. We report a patient who responded to radiotherapy but not interferon alpha.
引用
收藏
页码：291 / 294
页数：4
相关论文
共 50 条
  • [41] Emerging therapies for systemic lupus erythematosus - Focus on targeting interferon-alpha
    Lichtman, Eben I.
    Helfgott, Simon M.
    Kriegel, Martin A.
    [J]. CLINICAL IMMUNOLOGY, 2012, 143 (03) : 210 - 221
  • [42] Interest of interferon alpha in systemic mastocytosis.: The French experience and review of the literature
    Simon, J
    Lortholary, O
    Caillat-Vigneron, N
    Raphaël, M
    Martin, A
    Brière, J
    Barète, S
    Hermine, O
    Casassus, P
    [J]. PATHOLOGIE BIOLOGIE, 2004, 52 (05): : 294 - 299
  • [43] Clinical stable systemic mastocytosis with interferon alpha-2b therapy
    Hubner, C
    Wedding, U
    Strater, J
    Limberg, B
    Stremmel, W
    [J]. JOURNAL OF INTERNAL MEDICINE, 1997, 241 (06) : 529 - 533
  • [44] Treatment of three patients with systemic mastocytosis with interferon alpha-2b
    Worobec, AS
    Kirshenbaum, AS
    Schwartz, LB
    Metcalfe, DD
    [J]. LEUKEMIA & LYMPHOMA, 1996, 22 (5-6) : 501 - 508
  • [45] Successful treatment of osteoporosis in systemic: Mastocytosis with interferon alpha-2b
    Weide, R
    Ehlenz, K
    Lorenz, W
    Walthers, E
    Klausmann, M
    Pfluger, KH
    [J]. ANNALS OF HEMATOLOGY, 1996, 72 (01) : 41 - 43
  • [46] INTERFERON-ALPHA REGULATION OF LYMPHOCYTE FUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SIBBITT, WL
    FROELICH, CJ
    BANKHURST, AD
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1984, 32 (01): : 70 - 80
  • [47] Efficacy and safety of systemic recombinant interferon-alpha in Behcet's disease
    Georgiou, S
    Monastirli, A
    Pasmatzi, E
    Gartaganis, S
    Goerz, G
    Tsambaos, D
    [J]. JOURNAL OF INTERNAL MEDICINE, 1998, 243 (05) : 367 - 372
  • [48] NEUTRALIZING ANTIBODIES TO INTERFERON-ALPHA - RELATIVE FREQUENCY IN PATIENTS TREATED WITH DIFFERENT INTERFERON PREPARATIONS
    ANTONELLI, G
    CURRENTI, M
    TURRIZIANI, O
    DIANZANI, F
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04): : 882 - 885
  • [49] TREATMENT OF 3 PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH INTERFERON-ALPHA-2B
    WOROBEC, AS
    KIRSHENBAUM, AS
    SCHWARTZ, LB
    METCALFE, DD
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 364 - 364
  • [50] SYSTEMIC INTERFERON-ALPHA IN THE TREATMENT OF HTLV-I-ASSOCIATED MYELOPATHY
    KURODA, Y
    KUROHARA, K
    FUJIYAMA, F
    TAKASHIMA, H
    ENDO, C
    MATSUI, M
    NESHIGE, R
    KAKIGI, R
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1992, 86 (01): : 82 - 86
12345